Allan Kirk
4Patents
0h-index
7Co-inventors
31Inventor score
Filing activity: Jan 20, 2010 → Apr 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10488413B2 | Methods for treating patients at risk for costimulation blockade resistant rejection with belatacept | Physics | 0 | Active |
| US8546095B2 | Methods for determination of calcineurin activity and uses in predicting therapeutic outcomes | Emerging Cross-Sectional Technologies | 0 | Active |
| US11385228B2 | Methods for treating costimulation blockade resistant rejection | Physics | 0 | Active |
| US12084509B2 | Gene signatures for monitoring acute rejection and methods of using same | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.